Profil
Rolf Magnus Björsne is currently the Chief Executive Officer at AstraZeneca BioVentureHub AB, Chairman at Termino C 2915 AB, and Director at SwedenBIO Service AB. He previously worked as a Director at Beactica Therapeutics AB from 2014 to 2018 and as an Independent Director at Isofol Medical AB from 2018 to 2023.
Björsne holds a doctorate from the University of Stockholm and an MBA from Henley Management College.
Aktive Positionen von Rolf Magnus Björsne
| Unternehmen | Position | Beginn |
|---|---|---|
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services Provides educational services | Direktor/Vorstandsmitglied | - |
Termino C 2915 AB | Vorsitzender | - |
AstraZeneca BioVentureHub AB | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Rolf Magnus Björsne
| Unternehmen | Position | Ende |
|---|---|---|
| ISOFOL MEDICAL AB | Direktor/Vorstandsmitglied | 01.02.2023 |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Operates as a drug discovery company | Direktor/Vorstandsmitglied | 01.01.2018 |
Ausbildung von Rolf Magnus Björsne
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
University of Stockholm
University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Henley Management College
Henley Management College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Operates as a drug discovery company | Distribution Services |
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services Provides educational services | Commercial Services |
Isofol Medical AB
Isofol Medical AB Pharmaceuticals: MajorHealth Technology Provides novel folate-based pharmaceutical products | Health Technology |
Termino C 2915 AB | |
AstraZeneca BioVentureHub AB |
















